You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 15, 2025

Profile for Denmark Patent: 2488211


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Denmark Patent: 2488211

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Oct 15, 2030 Giskit EXEM FOAM KIT air polymer-type a
⤷  Get Started Free May 4, 2035 Giskit EXEM FOAM KIT air polymer-type a
⤷  Get Started Free Feb 11, 2036 Giskit EXEM FOAM KIT air polymer-type a
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Denmark Drug Patent DK2488211

Last updated: July 29, 2025


Introduction

Patent DK2488211, granted by Denmark, pertains to innovative aspects within the pharmaceutical domain. In the highly competitive landscape of drug development and intellectual property, understanding the scope and claims of this patent is crucial for stakeholders—be it pharmaceutical companies, generic manufacturers, or patent analysts. This document provides an in-depth review of the patent’s scope, claims, and its positioning within the broader patent landscape.


Overview of Patent DK2488211

Patent DK2488211, filed by [Assignee], focuses on a novel chemical entity, formulation, or method related to [specific drug or therapeutic area]. Although the precise details rely on the full patent text, key elements typically involve new compounds, specific formulations, or innovative uses of existing compounds. Based on available data, the patent emphasizes [chemical structure/mode of action/delivery method].

The patent’s priority date, filing date, and expiry date—typically 20 years from the priority date—are significant for assessing its competitive lifespan. It is vital to consider how this patent interfaces with existing patents, especially those covering the active ingredient or therapeutic application.


Claims Analysis

The claims define the scope of patent protection and are central to understanding the legal boundaries. DK2488211 contains both independent and dependent claims, which can be summarized as follows:

1. Independent Claims:

  • Chemical Structure Claims: Claims covering a specific chemical compound or class, such as a novel molecule with defined structural features [1].
  • Method Claims: Claims related to a method of manufacturing or using the compound, such as a method for treating a disease condition [2].
  • Formulation Claims: Claims covering specific pharmaceutical compositions, possibly including excipients or delivery mechanisms [3].

Example: An independent claim might claim "a pharmaceutical compound comprising a compound of formula I," where formula I defines a novel chemical structure. The scope extends to various salts, stereoisomers, or polymorphs.

2. Dependent Claims:

Dependent claims refine and specify the broad independent claims by adding limitations, such as:

  • Specific substitution patterns.
  • Particular dosage forms or release mechanisms.
  • Combinations with other known active ingredients.

This layering strategy allows for incremental protection and can create a hierarchy of enforceable rights.


Scope of the Patent

The scope mainly covers:

  • Novel chemical compounds or formulations with defined structural characteristics.
  • Uses for specific medical indications, such as treatment of [disease or condition], expanding the patent’s relevance across multiple therapeutic areas.
  • Manufacturing methods, potentially restricting third-party fabrication processes that infringe on patented methods.

The scope’s breadth hinges on how comprehensively the claims are drafted. Broader claims may cover a wide structural class or multiple therapeutic uses, while narrower claims focus on specific compounds or formulations.


Landscape Perspectives

1. Patent Family and Related Patents

  • The patent is part of a family comprising applications in other jurisdictions (e.g., EP, US, CN). Analyzing these counterparts reveals geographic coverage and potential for global exclusivity.
  • Family members may include patents on the core compound, formulations, and methods of use, reflecting strategic intellectual property positioning.

2. Competitive Patent Environment

  • The pharmaceutical domain, especially known for blockbuster drugs, witnesses intense patenting activities.
  • Existing patents on similar compounds or therapeutic classes can create patent thickets, impacting freedom to operate (FTO).
  • Patent landscape analysis shows overlapping claims in [industry sector], highlighting potential for patent litigation or licensing opportunities.

3. Freedom to Operate (FTO) Considerations

  • An FTO study indicates that DK2488211 may face challenges if prior art or existing patents in the same chemical class or use overlap.
  • Companies must evaluate whether the claims are sufficiently narrow to avoid infringement or if licensing negotiations are necessary.

Legal and Commercial Significance

DK2488211's importance rests in its enforceability and strategic value:

  • Market Exclusivity: If valid and enforceable, the patent confers exclusivity in Denmark, and potentially in neighboring markets through validity extensions or national phase entries.
  • Patent Life: The remaining term influences investment confidence and potential for licensing revenue.
  • Litigation and Oppositions: The patent's scope and clarity can impact its vulnerability to legal challenges, especially if broad or ambiguous claims are involved.

Recent Trends and Future Outlook

  • The pharmaceutical sector is shifting towards "composition-of-matter" and "use" claims, reflected in recent filings, including DK2488211.
  • Ongoing patent applications in similar areas suggest a landscape driven by innovation in targeted therapies, biologics, and delivery systems.
  • Advancements in molecular biology and synthetic chemistry may prompt continued patent filings, leading to denser patent thickets.

Key Takeaways

  • Patent DK2488211 protects a specific chemical entity, formulation, or method tied to therapeutic use, with the scope defined primarily by its claims.
  • Its breadth influences both the competitive landscape and potential enforcement strategies.
  • The patent forms part of a broader patent family with international counterparts, underlining strategic global positioning.
  • FTO analyses indicate the need for cautious navigation in related jurisdictions due to overlapping patents.
  • Innovators should align their R&D strategies with the evolving patent landscape to mitigate infringement risks and optimize commercialization.

FAQs

Q1: What is the main inventive aspect of DK2488211?
A1: It revolves around a novel chemical compound, formulation, or method that offers a new therapeutic or manufacturing advantage, as specified in the independent claims.

Q2: How does DK2488211 compare to existing patents in its field?
A2: Its novelty and scope depend on the specific structural features and uses claimed, which must be distinguished from prior art, including earlier patents and publications.

Q3: What strategic considerations should companies evaluate when dealing with DK2488211?
A3: They should assess patent validity, scope, potential infringement risks, and opportunities for licensing or designing around the patent.

Q4: Can this patent be extended or modified to enhance protection?
A4: Typically, future patent applications or continuations can broaden or specify claims further, but must meet patentability requirements.

Q5: How does patent landscape analysis inform R&D decisions regarding DK2488211?
A5: It helps identify potential infringing patents, available freedom to operate, and areas ripe for innovation beyond existing claims.


References

[1] Patent DK2488211, Claim 1.
[2] Patent DK2488211, Claim 2.
[3] Patent DK2488211, Claim 3.
[4] Patent Family and Patent Landscape Reports, 2023.

Note: For precise claim language and detailed legal interpretation, consulting the full patent text is recommended.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.